← FDA Drug Approvals (Drugs@FDA)

EPHEDRINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2023-03-09

Drug application

FDA Application #

ANDA214528

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPHEDRINE SULFATE

Generic name

EPHEDRINE SULFATE

Active ingredients

EPHEDRINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2023-03-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown